LifeCannMD
APRIL 28, 2025
Scientists had published legitimate research findings showing that cannabis compounds had actually slowed tumor growth in mice. He developed a concentrated oil from the cannabis plant and decided to try it on himself. He developed a concentrated oil from the cannabis plant and decided to try it on himself. Not Rick Simpson.
PrestoDoctor
NOVEMBER 7, 2023
As Indigenous Peoples’ Month is celebrated, it is important to acknowledge and honor the contributions, cultures, and history of indigenous communities around the world. Indigenous communities have a rich history of utilizing this plant for various purposes, including medicinal, spiritual, and cultural uses.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
AUGUST 3, 2021
million research partnership with an industry leader consortium through Protein Industries Canada. Manitoba, NRGene, Farmer’s Business Network and Pulse Genetics will be developing new hemp and pea varieties with increased protein content, differential starch content, and improved texture. Source: [link].
Cannabis Law Report
AUGUST 10, 2021
As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.
Project CBD
NOVEMBER 11, 2023
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
Veriheal
MARCH 17, 2022
However, new research has found that psychedelic use is only “weakly associated with psychosis-like symptoms.” New Research Published on Serotonergic Psychedelic Use and Psychosis. New Research Published on Serotonergic Psychedelic Use and Psychosis. The research team under the leadership of Alexander V.
Cannabis Law Report
SEPTEMBER 10, 2021
DUBLIN–(BUSINESS WIRE)–The “Dyskinesia (Central Nervous System) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Dyskinesia – Drugs In Development, 2021, provides an overview of the Dyskinesia (Central Nervous System) pipeline landscape.
Expert insights. Personalized for you.
82 
Let's personalize your content